S&P 500   4,238.11 (-1.17%)
DOW   33,088.66 (-1.03%)
QQQ   355.98 (-1.46%)
AAPL   172.49 (-0.73%)
MSFT   313.66 (-2.53%)
META   301.07 (-1.87%)
GOOGL   132.85 (-0.98%)
AMZN   125.34 (-3.18%)
TSLA   248.74 (-1.14%)
NVDA   440.41 (-1.65%)
NIO   8.73 (-0.68%)
BABA   84.81 (-1.99%)
AMD   100.90 (-2.29%)
T   14.63 (-0.27%)
F   12.13 (-1.46%)
MU   68.63 (+0.99%)
CGC   0.70 (-4.57%)
GE   107.76 (-0.95%)
DIS   79.81 (-2.28%)
AMC   8.02 (-1.60%)
PFE   33.92 (-0.06%)
PYPL   57.78 (-1.33%)
NFLX   379.34 (-0.26%)
S&P 500   4,238.11 (-1.17%)
DOW   33,088.66 (-1.03%)
QQQ   355.98 (-1.46%)
AAPL   172.49 (-0.73%)
MSFT   313.66 (-2.53%)
META   301.07 (-1.87%)
GOOGL   132.85 (-0.98%)
AMZN   125.34 (-3.18%)
TSLA   248.74 (-1.14%)
NVDA   440.41 (-1.65%)
NIO   8.73 (-0.68%)
BABA   84.81 (-1.99%)
AMD   100.90 (-2.29%)
T   14.63 (-0.27%)
F   12.13 (-1.46%)
MU   68.63 (+0.99%)
CGC   0.70 (-4.57%)
GE   107.76 (-0.95%)
DIS   79.81 (-2.28%)
AMC   8.02 (-1.60%)
PFE   33.92 (-0.06%)
PYPL   57.78 (-1.33%)
NFLX   379.34 (-0.26%)
S&P 500   4,238.11 (-1.17%)
DOW   33,088.66 (-1.03%)
QQQ   355.98 (-1.46%)
AAPL   172.49 (-0.73%)
MSFT   313.66 (-2.53%)
META   301.07 (-1.87%)
GOOGL   132.85 (-0.98%)
AMZN   125.34 (-3.18%)
TSLA   248.74 (-1.14%)
NVDA   440.41 (-1.65%)
NIO   8.73 (-0.68%)
BABA   84.81 (-1.99%)
AMD   100.90 (-2.29%)
T   14.63 (-0.27%)
F   12.13 (-1.46%)
MU   68.63 (+0.99%)
CGC   0.70 (-4.57%)
GE   107.76 (-0.95%)
DIS   79.81 (-2.28%)
AMC   8.02 (-1.60%)
PFE   33.92 (-0.06%)
PYPL   57.78 (-1.33%)
NFLX   379.34 (-0.26%)
S&P 500   4,238.11 (-1.17%)
DOW   33,088.66 (-1.03%)
QQQ   355.98 (-1.46%)
AAPL   172.49 (-0.73%)
MSFT   313.66 (-2.53%)
META   301.07 (-1.87%)
GOOGL   132.85 (-0.98%)
AMZN   125.34 (-3.18%)
TSLA   248.74 (-1.14%)
NVDA   440.41 (-1.65%)
NIO   8.73 (-0.68%)
BABA   84.81 (-1.99%)
AMD   100.90 (-2.29%)
T   14.63 (-0.27%)
F   12.13 (-1.46%)
MU   68.63 (+0.99%)
CGC   0.70 (-4.57%)
GE   107.76 (-0.95%)
DIS   79.81 (-2.28%)
AMC   8.02 (-1.60%)
PFE   33.92 (-0.06%)
PYPL   57.78 (-1.33%)
NFLX   379.34 (-0.26%)
NASDAQ:LFVN

LifeVantage (LFVN) Stock Forecast, Price & News

$6.51
-0.19 (-2.84%)
(As of 12:33 PM ET)
Compare
Today's Range
$6.44
$6.68
50-Day Range
$4.72
$7.51
52-Week Range
$3.04
$7.89
Volume
13,865 shs
Average Volume
40,285 shs
Market Capitalization
$82.74 million
P/E Ratio
32.55
Dividend Yield
2.15%
Price Target
N/A

LifeVantage MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.08% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.50
Upright™ Environmental Score
News Sentiment
1.13mentions of LifeVantage in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$175,227 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.43 out of 5 stars

Medical Sector

230th out of 976 stocks

Pharmaceutical Preparations Industry

85th out of 447 stocks


LFVN stock logo

About LifeVantage (NASDAQ:LFVN) Stock

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

LFVN Price History

LFVN Stock News Headlines

Ben Stein FREE Report: How Americans Are RUINING Retirement
There’s a new report just out from famed author, actor and economist Ben Stein. In this FREE REPORT, Ben reveals the lessons he learned from his late father and economist Herbert Stein. Discover how everyday Americans are currently ruining their retirements, and how YOU can save yours!
LifeVantage Files Definitive Proxy Statement
Ben Stein FREE Report: How Americans Are RUINING Retirement
There’s a new report just out from famed author, actor and economist Ben Stein. In this FREE REPORT, Ben reveals the lessons he learned from his late father and economist Herbert Stein. Discover how everyday Americans are currently ruining their retirements, and how YOU can save yours!
Q4 2023 LifeVantage Corp Earnings Call
LifeVantage (NASDAQ: LFVN)
3 Top Stocks to Buy in the #1 Ranked Industry
LifeVantage Extends Stock Repurchase Program
See More Headlines
Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Company Calendar

Last Earnings
8/28/2023
Ex-Dividend for 9/22 Dividend
9/07/2023
Dividend Payable
9/22/2023
Today
10/03/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:LFVN
Employees
248
Year Founded
N/A

Profitability

Net Income
$2.54 million
Pretax Margin
1.87%

Debt

Sales & Book Value

Annual Sales
$213.40 million
Cash Flow
$0.54 per share
Book Value
$2.71 per share

Miscellaneous

Free Float
11,848,000
Market Cap
$85.16 million
Optionable
Optionable
Beta
0.86
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Steven R. Fife (Age 62)
    Pres, CEO & Director
    Comp: $882.36k
  • Mr. Carl A. Aure (Age 50)
    Chief Financial Officer
    Comp: $534.78k
  • Ms. Julie Boyster (Age 38)
    Chief Marketing Officer
    Comp: $434.62k
  • Mr. Eric E. Marchant
    VP of Compliance
  • Ms. Alissa Neufeld (Age 44)
    Gen. Counsel & Corp. Sec.
  • Chris Taylor
    Director of Communications
  • Ms. Kristen Cunningham (Age 39)
    Chief Sales Officer
  • Ms. Michelle Oborn-Virchow (Age 43)
    Chief People Officer
  • Ms. Calli Mott
    Sr. VP of Distributor Experience
  • Mr. Eiichi Shiokawa
    Managing Director - Japan













LFVN Stock - Frequently Asked Questions

How have LFVN shares performed in 2023?

LifeVantage's stock was trading at $3.72 at the start of the year. Since then, LFVN stock has increased by 80.1% and is now trading at $6.70.
View the best growth stocks for 2023 here
.

Are investors shorting LifeVantage?

LifeVantage saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 110,600 shares, a drop of 23.1% from the August 31st total of 143,800 shares. Based on an average daily trading volume, of 73,500 shares, the days-to-cover ratio is presently 1.5 days. Approximately 1.1% of the shares of the stock are sold short.
View LifeVantage's Short Interest
.

When is LifeVantage's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our LFVN earnings forecast
.

How were LifeVantage's earnings last quarter?

LifeVantage Co. (NASDAQ:LFVN) posted its quarterly earnings data on Monday, August, 28th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by $0.03. The firm earned $54.22 million during the quarter. LifeVantage had a trailing twelve-month return on equity of 9.27% and a net margin of 1.19%. During the same quarter in the previous year, the firm earned $0.01 earnings per share.

How often does LifeVantage pay dividends? What is the dividend yield for LifeVantage?

LifeVantage declared a None dividend on Monday, August 28th. Shareholders of record on Friday, September 8th will be given a dividend of $0.435 per share on Friday, September 22nd. This represents a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, September 7th.
Read our dividend analysis for LFVN
.

Is LifeVantage a good dividend stock?

LifeVantage (NASDAQ:LFVN) pays an annual dividend of $0.14 per share and currently has a dividend yield of 2.17%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 70.00%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for LFVN.

What guidance has LifeVantage issued on next quarter's earnings?

LifeVantage updated its FY 2024 earnings guidance on Monday, August, 28th. The company provided earnings per share (EPS) guidance of $0.52-$0.62 for the period. The company issued revenue guidance of $216.00 million-$226.00 million.

What is Darren Jensen's approval rating as LifeVantage's CEO?

5 employees have rated LifeVantage Chief Executive Officer Darren Jensen on Glassdoor.com. Darren Jensen has an approval rating of 79% among the company's employees.

What other stocks do shareholders of LifeVantage own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF), Acer Therapeutics (ACER), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA), Enphase Energy (ENPH), NewAge (NBEV), Catalyst Biosciences (CBIO), Chesapeake Energy (CHKAQ) and ConocoPhillips (COP).

What is LifeVantage's stock symbol?

LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."

How do I buy shares of LifeVantage?

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeVantage's stock price today?

One share of LFVN stock can currently be purchased for approximately $6.70.

How much money does LifeVantage make?

LifeVantage (NASDAQ:LFVN) has a market capitalization of $85.16 million and generates $213.40 million in revenue each year. The company earns $2.54 million in net income (profit) each year or $0.20 on an earnings per share basis.

How many employees does LifeVantage have?

The company employs 248 workers across the globe.

How can I contact LifeVantage?

LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The official website for the company is www.lifevantage.com. The company can be reached via phone at (801) 432-9000, via email at scott.vanwinkle@icrinc.com, or via fax at 801-880-0699.

This page (NASDAQ:LFVN) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -